Intuitive Surgical Inc (ISRG)
398.82
+2.39
(+0.60%)
USD |
NASDAQ |
May 17, 16:00
398.59
-0.23
(-0.06%)
Pre-Market: 20:00
Intuitive Surgical Cash from Investing (Quarterly): -128.50M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -128.50M |
December 31, 2023 | -1.044B |
September 30, 2023 | -446.60M |
June 30, 2023 | 557.60M |
March 31, 2023 | 573.10M |
December 31, 2022 | 574.80M |
September 30, 2022 | 544.50M |
June 30, 2022 | 466.20M |
March 31, 2022 | -214.70M |
December 31, 2021 | -641.00M |
September 30, 2021 | -838.80M |
June 30, 2021 | -384.70M |
March 31, 2021 | -597.00M |
December 31, 2020 | -334.30M |
September 30, 2020 | -1.026B |
June 30, 2020 | 536.70M |
March 31, 2020 | -117.10M |
December 31, 2019 | -406.20M |
September 30, 2019 | -216.60M |
June 30, 2019 | -222.70M |
March 31, 2019 | -308.90M |
December 31, 2018 | -486.30M |
September 30, 2018 | -572.60M |
June 30, 2018 | -44.30M |
March 31, 2018 | 53.60M |
Date | Value |
---|---|
December 31, 2017 | -315.80M |
September 30, 2017 | -260.00M |
June 30, 2017 | -353.80M |
March 31, 2017 | 1.308B |
December 31, 2016 | -309.00M |
September 30, 2016 | -541.30M |
June 30, 2016 | -237.20M |
March 31, 2016 | -191.90M |
December 31, 2015 | -413.10M |
September 30, 2015 | -338.80M |
June 30, 2015 | -9.90M |
March 31, 2015 | -87.70M |
December 31, 2014 | -203.50M |
September 30, 2014 | -258.70M |
June 30, 2014 | 513.60M |
March 31, 2014 | -205.30M |
December 31, 2013 | -63.20M |
September 30, 2013 | 613.20M |
June 30, 2013 | 57.00M |
March 31, 2013 | -348.00M |
December 31, 2012 | -142.70M |
September 30, 2012 | -177.90M |
June 30, 2012 | -116.90M |
March 31, 2012 | -408.20M |
December 31, 2011 | -138.40M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.044B
Minimum
Dec 2023
574.80M
Maximum
Dec 2022
-168.27M
Average
-219.65M
Median
Cash from Investing (Quarterly) Benchmarks
Abbott Laboratories | -425.00M |
Becton Dickinson & Co | -1.056B |
PROCEPT BioRobotics Corp | -1.946M |
Alphatec Holdings Inc | -33.62M |
Masimo Corp | -18.90M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 265.40M |
Cash from Financing (Quarterly) | -46.70M |
Free Cash Flow | 595.80M |
Free Cash Flow Per Share (Quarterly) | 0.0652 |
Free Cash Flow to Equity (Quarterly) | 23.50M |
Free Cash Flow to Firm (Quarterly) | 23.50M |
Free Cash Flow Yield | 0.42% |